BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 31077550)

  • 21. Diagnostic Value of
    Voskuilen CS; Schweitzer D; Jensen JB; Nielsen AM; Joniau S; Muilwijk T; Necchi A; Azizi M; Spiess PE; Briganti A; Bandini M; Goffin K; Bouchelouche K; van Werkhoven E; Shariat SF; Xylinas E; Azawi NH; Ku JH; Foerster B; van Rhijn BWG; Vegt E; Hendricksen K
    Eur Urol Oncol; 2020 Feb; 3(1):73-79. PubMed ID: 31591037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sentinel node biopsy in squamous-cell carcinoma of the anal canal.
    De Nardi P; Carvello M; Canevari C; Passoni P; Staudacher C
    Ann Surg Oncol; 2011 Feb; 18(2):365-70. PubMed ID: 20803079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can the radiation dose to CT-enlarged but FDG-PET-negative inguinal lymph nodes in anal cancer be reduced?
    Mai SK; Welzel G; Hermann B; Wenz F; Haberkorn U; Dinter DJ
    Strahlenther Onkol; 2009 Apr; 185(4):254-9. PubMed ID: 19370429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients.
    Crivellaro C; Landoni C; Elisei F; Buda A; Bonacina M; Grassi T; Monaco L; Giuliani D; Gotuzzo I; Magni S; Di Martino G; Delle Marchette M; Guerra L; Landoni F; Fruscio R; Messa C; De Bernardi E
    Int J Gynecol Cancer; 2020 Mar; 30(3):378-382. PubMed ID: 32079712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing
    Sarikaya I; Sarikaya A
    J Nucl Med Technol; 2019 Jun; 47(2):149-153. PubMed ID: 30413593
    [No Abstract]   [Full Text] [Related]  

  • 26. Which is better for predicting pelvic lymph node metastases in patients with cervical cancer: Fluorodeoxyglucose-positron emission tomography/computed tomography or a sentinel node biopsy? A retrospective observational study.
    Tanaka T; Sasaki S; Tsuchihashi H; Terai Y; Yamamoto K; Yamada T; Ohmichi M
    Medicine (Baltimore); 2018 Apr; 97(16):e0410. PubMed ID: 29668599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The combination of preoperative PET/CT and sentinel lymph node biopsy in the surgical management of early-stage cervical cancer.
    Papadia A; Gasparri ML; Genoud S; Bernd K; Mueller MD
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2275-2281. PubMed ID: 28669052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of tumour burden assessed by metabolic tumour volume on FDG PET/CT in anal canal cancer.
    Gauthé M; Richard-Molard M; Fayard J; Alberini JL; Cacheux W; Lièvre A
    Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):63-70. PubMed ID: 27503193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Groin sentinel node biopsy and
    Garganese G; Collarino A; Fragomeni SM; Rufini V; Perotti G; Gentileschi S; Evangelista MT; Ieria FP; Zagaria L; Bove S; Giordano A; Scambia G
    Eur J Surg Oncol; 2017 Sep; 43(9):1776-1783. PubMed ID: 28751058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FDG-PET for axillary lymph node staging in primary breast cancer.
    Crippa F; Gerali A; Alessi A; Agresti R; Bombardieri E
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31 Suppl 1():S97-102. PubMed ID: 15133635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma.
    Stoeckli SJ; Steinert H; Pfaltz M; Schmid S
    Head Neck; 2002 Apr; 24(4):345-9. PubMed ID: 11933176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of clinical impact of
    Liu J; Larcos G; Howle J; Veness M
    Australas J Dermatol; 2017 May; 58(2):99-105. PubMed ID: 26459330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma.
    Havenga K; Cobben DC; Oyen WJ; Nienhuijs S; Hoekstra HJ; Ruers TJ; Wobbes T
    Eur J Surg Oncol; 2003 Oct; 29(8):662-4. PubMed ID: 14511614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness and potential pitfalls of pre-operative PET-CT in patients with endometrial cancer undergoing one- and two-step sentinel lymph node mapping: Do negative findings on PET-CT negativity really indicate node negativity?
    Kim YN; Lee D; Cha J; Kang WJ; Lee YJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
    Gynecol Oncol; 2022 Sep; 166(3):438-443. PubMed ID: 35907682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical relevance of positron emission tomography/computed tomography-positive inguinal nodes in rectal cancer after neoadjuvant chemoradiation.
    Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Ono CR; Lynn P; Bailão Aguilar P; Nahas SC; Gama-Rodrigues J; Buchpiguel CA
    Colorectal Dis; 2013 Jun; 15(6):674-82. PubMed ID: 23374979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discordant results in
    Parisse-Di Martino S; Faure C; Mognetti T
    Cancer Treat Res Commun; 2021; 27():100344. PubMed ID: 33636590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Axillary staging using positron emission tomography in breast cancer patients qualifying for sentinel lymph node biopsy.
    Fehr MK; Hornung R; Varga Z; Burger D; Hess T; Haller U; Fink D; von Schulthess GK; Steinert HC
    Breast J; 2004; 10(2):89-93. PubMed ID: 15009033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18F-FDG PET/CT in preoperative staging of vulvar cancer patients: is it really effective?
    Crivellaro C; Guglielmo P; De Ponti E; Elisei F; Guerra L; Magni S; La Manna M; Di Martino G; Landoni C; Buda A
    Medicine (Baltimore); 2017 Sep; 96(38):e7943. PubMed ID: 28930828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma.
    Singh B; Ezziddin S; Palmedo H; Reinhardt M; Strunk H; Tüting T; Biersack HJ; Ahmadzadehfar H
    Melanoma Res; 2008 Oct; 18(5):346-52. PubMed ID: 18781133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-up.
    Agresti R; Crippa F; Sandri M; Martelli G; Tagliabue E; Alessi A; Pellitteri C; Maccauro M; Maugeri I; Barbara P; Rampa M; Moscaroli A; Ferraris C; Carcangiu ML; Bianchi G; Greco M; Bombardieri E
    Breast; 2014 Aug; 23(4):334-40. PubMed ID: 24485802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.